Ranbaxy and Cipher Announce Signing of Licensing Agreement for Isotretinoin

Ranbaxy Laboratories Ltd has informed BSE regarding a Press Release dated July 24, 2014 titled "Ranbaxy and Cipher Announce Signing of Licensing Agreement for Isotretinoin".

Source : BSE - >www.bseindia.com

Published on July 24, 2014
TOPICS

Related

This article is closed for comments.
Please Email the Editor